Platelet concentrates from automated apheresis - Past, present and future developments

Infusionstherapie und Transfusionsmedizin

Volumn 27, Issue 3, 2000, Pages 119-126

  Zeiler, T ^a   Kretschmer, V ^b  

^a UNIVERSITY HOSPITAL MARBURG   (Germany)

^b NONE

Author keywords

Cytapheresis; Platelet concentrate; Plateletpheresis

Indexed keywords

FRESH FROZEN PLASMA; THROMBOCYTE CONCENTRATE;

AUTOANALYZER; BLOOD DONOR; BLOOD TRANSFUSION REACTION; CENTRIFUGATION; CYTAPHERESIS; HLA SYSTEM; IMMUNIZATION; QUALITY CONTROL; REVIEW; THROMBOCYTOPHERESIS; VIRUS INACTIVATION;

EID: 0034089629     PISSN: 10198466     EISSN: None     Source Type: Journal    
DOI: 10.1159/000025256     Document Type: Review

References (79)

1. Duke WW: The relation of blood platelets to hemorrhagic disease: Description of a method for determining the bleeding time and coagulation time and report of three cases of hemorrhagic disease relieved by transfusion. JAMA 1910;55:1185-1192.
2. Hirsch EO, Gardner FH: The transfusion of human blood platelets. J Lab Clin Med 1952;39:556-569.
3. Walter CW, Murphy WP: A closed gravity technique for the preservation of whole blood in ACD solution utilizing plastic equipment. Surg Gyn Obst 1952;94:687-692.
4. Miller WV, Gillem HG: Platelet concentrations in batches using the latham centrifuge bowl. Vox Sang 1969;17:21.
5. Latham AJ: Early developments in blood cell separation technology. Vox Sang 1986;51:249-252.
6. Latham AJ, Kingsley GF: Cell separator design considerations; in Goldman JM, Lowenthal RM (eds): Leucocytes: Separation, Collection and Transfusion. London, Academic Press, 1975, pp 203-207.
7. Latham AJ, Tinch R, Tullis JL: Automation of the blood research institute glycerol method of processing red cells in the latham processor. Vox Sang 1969;17:19.
8. Kurtz SR: Plateletpheresis experience with the Haemonetics Blood Processor 30, the IBM Blood Processor 2997, and the Fenwal CS-3000 Blood Processor. Vox Sang 1981;41:212-218.
9. Lasky LC, Lin A, Kahn RA, McCullough J: Donor platelet response and product quality assurance in plateletpheresis. Transfusion 1981;21:247-260.
10. Wissenschaftlicher Beirat der Bundesärztekammer und Paul-Ehrlich-Institut. Richtlinien zur Blutgruppenbestimmung und Bluttransfusion (Hämotherapie). Köln, Deutscher Ärzte-Verlag GmbH, 1996.
11. Misterek J, Mueller-Eckhardt C: Zum Problem der Partikelbildung in Einmalsystemen fur den Zellseparator V.50.1 (Haemonetics); in Kretschmer V, Stangel W, Weißhaar D (Hrsg): Transfusionsmedizin 1990/91. Beitr Infusionsther. Basel, Karger, 1991, vol 28, pp 159-161.
12. Kretschmer V: Side-effects and technical problems in cytapheresis with cell separators. Results of a retrospective multicenter study. Infusionsther Klin Ernähr 1987;14(suppl 4):7-16.
13. Sweeney JD, Petrucci J, Yankee R: Pooled platelet concentrates: Maybe not fancy, but fiscally sound and effective. Transfus Sci 1997;18:575-583.
14. McLeod BC, Price TH, Owen H, Ciavarella D, Sniecinski I, Randels MJ, Smith JW: Frequency of immediate adverse effects associated with apheresis donation. Transfusion 1998;38:938-943.
15. Moog R: Mitteilungen über unerwünschte Störungen und Nebenwirkungen der präparativen Hämapherese 1996. Infusionsther Transfusionsmed 1998; 25:183-184.
16. Burgstaler EA: Current instrumentation for apheresis; in McLeod BC, Price TH, Drew MJ (eds): Apheresis: Principles and Practice. Bethesda, AABB Press, 1997, pp 85-112.
17. Zingsem J, Weisbach V, Zeiler T, Zimmermann R, Neidhardt B, Eckstein R: Are single-needle protocols equivalent to dual-needle protocols for platelet apheresis? in Sibrowski W, Stangel W, Wegener S (Hrsg): Transfusionsmedizin 1993/94. Beitr Infusionsther Transfusionsmed. Basel, Karger, 1994, vol 32, pp 328-333.
18. Norol F, Kuentz M, Cordonnier C, Beaujean F, Haioun C, Vernant JP, Duedari N: Influence of clinical status on the efficiency of stored platelet transfusion. Br J Haematol 1994;86:125-129.
19. Harker LA, Roskos L, Cheung E: Effective and efficient platelet transfusion strategies that maintain hemostatic protection. Transfusion 1998;38: 619-621.
20. Hersh JK, Hom EG, Brecher ME: Mathematical modeling of platelet survival with implications for optimal transfusion practice in the chronically platelet transfusion-dependent patient. Transfusion 1998;38:637-644.
21. Zeger G, Williams CT, Shulman IA: Single donor platelets: Can we afford to use them? Can we afford not to use them? Transfus Sci 1997;18:585-588.
22. Barrett BB, Andersen JW, Anderson KC: Strategies for the avoidance of bacterial contamination of blood components. Transfusion 1993;33:228-233.
23. Alvarez FE, Rogge KJ, Tarrand J, Lichtiger B: Bacterial contamination of cellular blood components. A retrospective review at a large cancer center. Ann Clin Lab Sci 1995;25:283-290.
24. Fijnheer R, Pietersz RN, de Korte D, Gouwerok CW, Dekker WJ, Reesink HW, Roos D: Platelet activation during preparation of platelet concentrates: A comparison of the platelet-rich plasma and the buffy coat methods. Transfusion 1990;30: 634-638.
25. Sloand EM, Yu M, Klein HG: Comparison of random-donor platelet concentrates prepared from whole blood units and platelets prepared from single-donor apheresis collections. Transfusion 1996; 36:955-959.
26. Zeiler T, Schulzki T, Wilbert U, Kretschmer V: In vitro evaluation of platelet concentrates with respect to preparation technique and storage time. Infusionsther Transfusionsmed 1995;22:54-54.
27. Kretschmer V, Planitz C, Dietrich G, Pflueger HH: Transfusion results of platelet concentrates using different cell separators. Infusionstherapie 1991;18: 196-198.
28. Turner VS, Hawker RJ, Mitchell SG, Seymour Mead AM: Paired in vivo and in vitro comparison of apheresis and 'recovered' platelet concentrates stored for 5 days. J Clin Apheresis 1994;9:189-194.
29. Dzik S: Leukoreduction: Current state of the art. Infusionsther Transfusionsmed 1998;25:282-287.
30. Müller N: Leukozyten-Filtration; in Kretschmer V, Stangel W, Frey-Wettstein M (Hrsg): Transfusionsmedizin 1988. Infektionen, Plasamprodukte, Transplantationen, Antikörper. Beitr Infusionsther. Basel, Karger, 1989, vol 24, pp 237-242.
31. Zeiler T, Kretschmer V: In-line-Leukozytendepletion von Thrombozytapheresekonzentraten mit dem Fresenius-AS-104-Zell-Separator; in Sibrowski W, Stangel W, Müller N (Hrsg): Transfusionsmedizin 1996/97. Beitr Infusionsther Transfusionsmed. Basel, Karger, 1997, vol 34, pp 110-113.
32. Reesink HW, Nydegger UE, Brand: Should all platelet concentrates issued be leukocyte-poor? Vox Sang 1992;62:57-64.
33. Moog R, Mueller N, Koebke AC, Kalb R: Leukocyte filtration of single-donor platelet units through an integrated filter system for the Fresenius AS 104 blood cell separator. Vox Sang 1997;72:107-110.
34. Jarolim P: Value of leukocyte reduction debated. AABB News 1999;21:24.
35. Fried MR, Eastlund T, Christie B, Mullin GT, Key NS: Hypotensive reactions to white cell-reduced plasma in a patient undergoing angiotensin-converting enzyme inhibitor therapy. Transfusion 1996;36:900-903.
36. Shiba M, Tadokoro K, Sawanobori M, Nakajima K, Suzuki K, Juji T: Activation of the contact system by filtration of platelet concentrates with a negatively charged white cell-removal filter and measurement of venous blood bradykinin level in patients who received filtered platelets. Transfusion 1997;37:457-462.
37. Select Committee on Quality Assurance in Blood Transfusion Services: Guide to the Preparation, Use and Quality Assurance of Blood Components, 5th ed. Strasbourg Cedex, Council of Europe Publishing, 1999.
38. Grode G, Miripol J, Garber J, Barber T, Buchholz DH: Extended storage of platelets in a new plastic container. I. Biochemical and morphologic changes. Transfusion 1985;25:204-208.
39. Buchholz DH, Porten JH, Grode G, Lin AT, Smith J, Barber T, Brda J, Kozar I: Extended storage of single-donor platelet concentrate collected by a blood cell separator. Transfusion 1985;25:557-562.
40. Lohrmann HP, Bull MI, Decter JA, Yankee RA, Graw RGJ: Platelet transfusions from HL-A compatible unrelated donors to alloimmunized patients. Ann Intern Med 1974;80:9-14.
41. Yankee RA, Graff KS, Dowling R, Henderson ES: Selection of unrelated compatible platelet donors by lymphocyte HL-A matching. N Engl J Med 1973;288:760-764.
42. Yankee RA: Importance of histocompatibility in platelet transfusion therapy. Vox Sang 1971;20: 419-426.
43. Yankee RA, Grumet FC, Rogentine GN: Platelet transfusion. The selection of compatible platelet donors for refractory patients by lymphocyte HL-A typing. N Engl J Med 1969;281:1203-1212.
44. Wallace EL, Surgenor DM, Hao HS, An J, Chapman RH, Churchill WH: Collection and transfusion of blood and blood components in the United States, 1989. Transfusion 1993;33:139-144.
45. Devine P, Goldstein R, Linden JV, Postoway N, Hoffstadter LK, Hines DM: Data on apheresis, blood collection, and transfusion-related activities: Statistical analyses of the American Association of Blood Banks institutional membership questionnaires. Transfusion 1996;36:375-381.
46. Kretschmer V, Zeiler T: Platelet concentrates in Germany. Transfus Sci 1997;18:21-23.
47. Kao KJ, Mickel M, Braine HG, Davis K, Enright H, Gernsheimer T, Gillespie MJ, Kickler TS, Lee EJ, McCullough JJ, et al: White cell reduction in platelet concentrates and packed red cells by filtration: A multicenter clinical trial. The TRAP study group. Transfusion 1995;35:13-19.
48. Morgan S: Economic impact of using single-donor platelets. Infusionsther Transfusionsmed 1996;23 (suppl 1):30-40.
49. Zeiler T, Kretschmer V: Automated blood component collection with the MCS 3p cell separator: Evaluation of three protocols for buffy coat-poor and white cell-reduced packed red cells and plasma. Transfusion 1997;37:791-797.
50. Valbonesi AM, Florio G, Venturino V, Bruni R: Plateletpheresis: What's new? Transfus Sci 1996;17: 537-544.
51. Bessis M: Living Blood Cells and Their Ultrastructure. Berlin, Springer, 1973.
52. Valbonesi M, Bruni R, Florio G, Lercari G, Cantarella S, Torretta F: Automatic volumetric capillary cytometry in the routine of an apheresis unit involved in multicomponent collection. Transfus Sci 1999;21:117-121.
53. Yockey C Murphy S, Eggers L, Garratty G, Dingle A, Helms C, Moroff G: Evaluation of the Amicus Separator in the collection of apheresis platelets. Transfusion 1998;38:848-854.
54. Burgstaler EA, Pineda AA, Potter BM, Brown R: Plateletapheresis with a next generation blood cell separator. J Clin Apheresis 1997;12:55-62.
55. Brown R, Snyder E, Pineda A, Steenssens LA: A multicenter study of the leukocyte contamination of platelet products collected with the Amicus Separator. J Clin Apheresis 1996;11:103(abstract).
56. Soudavar F, Borberg H: Evaluation of the Haemonetics V50-time saver protocol. Infusionsther Transfusionsmed 1992;19:253-256.
57. Strauss RG, Halpern LN, Eckermann I: Comparison of autosurge versus surge protocols for discontinuous-flow centrifugation plateletapheresis. Transfusion 1987;27:499-501.
58. Szymanski IO, Ciavarella D, Rosohansky S, Napychank PA, Snyder EM: Evaluation of platelets collected by a new portable apheresis device. J Clin Apheresis 1993;8:66-71.
59. Twait J, Nash S, Kafka M: Evaluation of the Haemonetics MCS and MCS+ with in-line filtration. Transfusion 1995;35(suppl):53S(abstract).
60. Grima K, Ciavarella D, Rooney W: Comparison of platelets collected on the MCS and MCS+. J Clin Apheresis 1995;10:37(abstract).
61. Simon TL: The collection of platelets by apheresis procedures. Transfus Med Rev 1994;8:132-145.
62. Verba M, Yomtovian R, Keegan J: Double platelet product collection using the Haemonetics MCS+ apheresis system. J Clin Apheresis 1996;11:105(abstract).
63. Ford K, Thompson C, Mewhorter R: Evaluation of the Haemonetics MCS+ LN9000 to produce leukoreduced platelet products. J Clin Apheresis 1996; 11:104(abstract).
64. Rose C, Ragusa M, Andres M: Evaluation of the MCS+ LN9000 in-line leukoreduction filter. Transfusion 1996;36(suppl):85(abstract).
65. Maresh S, Randels M, Strauss R, Winegarden D, Ludwig GA: Comparison of plateletpheresis with a standard and an improved collection device. Transfusion 1993;33:835-837.
66. Kretschmer V: Comparison of different plateletpheresis systems. Infusionstherapie 1991;18:188-190.
67. Abreu ED, Strauss RG, Cordle DG, Kingery LR, Ludwig GA, Randels MJ: Providing leukocyte-reduced platelets using the CS-3000 PLUS. J Clin Apheresis 1996;11:27-29.
68. Burgstaler EA, Pineda AA, Brecher MA: Plateletpheresis: comparison of platelet yields, processing time, and white cell content with two apheresis systems. Transfusion 1993;33:393-398.
69. Kuriyan M, Opalka A: Leukoreduced platelet apheresis production with a modified COBE spectra collection protocol. J Clin Apheresis 1995;10: 85-86.
70. Ciavarella D, Sheehy J, Raucci E: Single needle versus dual needle plateletpheresis procedures using the Cobe Spectra, Version 4.3. J Clin Apheresis 1995;10:34(abstract).
71. Adams MR, Dumont LJ, McCall M, Heatom WA: Clinical trial and local process evaluation of an apheresis system for preparation of white cell-reduced platelet components. Transfusion 1998;38: 966-974.
72. Zingsem J, Glaser A, Weisbach V, Zimmermann R, Neidhardt B, van Waeg G, Eckstein R: Evaluation of a platelet apheresis technique for the preparation of leukocyte-reduced platelet concentrates. Vox Sang 1998;74:189-192.
73. Riggert J, Humpe A, Simson G, Koehler M: Quality and safety of platelet apheresis concentrates produced with a new leukocyte reduction system. Vox Sang 1998;74:182-188.
74. Fournel JJ, Zingsem J, Riggert J, Muylle L, Müller N, Kohler M, Beaumont JL, Baeten M, Eckstein R, van Waeg G: A multicenter evaluation of the routine use of a new white cell-reduction apheresis system for collection of platelets. Transfusion 1997; 37:487-492.
75. Zeiler T, Kretschmer V: In-line leukocyte depletion of thrombocyte apheresis concentrates. Infusionsther Transfusionsmed 1999;26:288-292.
76. Zeiler T, Zingsem J, Moog R, Kretschmer V, Eckstein R, Mueller N, et al: Periodic alternating interface positioning (PAIP) to lower WBC contamination of apheresis platelet concentrates - a multicenter evaluation. Transfusion 2000;40:(in press).
77. Valbonesi M, Frisoni R, Gianinni G, Florio G, Carlier P, Ruzzenenti M: Excel: A new cell separator in its very first clinical application. Infusionsther Transfusionsmed 1993;20:11-13.
78. Moog R, Mueller N, Nieper A: In-line filtration of platelet concentrates obtained with the Omnix blood cell separator. Transfus Med 1995;5:293-296.
79. Moog R, Luboldt W, Kruetzfeld A, Paar D, Holtmann M, Mengelkamp AK: Thrombozytapherese mit dem Zellseparator A 201 (Baxter) - erste Daten zur Biokompatibilität. Infusionstherapie 1991;18:244-247.